Meeting
2024 ASCO Annual Meeting
AI-based approach to enable proactive identification of early lung cancer: A retrospective population health study and economic model.
Authors
William Ricketts
Barts Health NHS Trust, London, United Kingdom
William Ricketts , Charles Gutteridge , Andrew Houston , Sophie Williams , Chris Tackaberry , Marcus Simon , Hilary Thomas , Maria Bogdanovskaya , Edward Tout , John Conibear
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 10536)
DOI
10.1200/JCO.2024.42.16_suppl.10536
Abstract #
10536
Poster Bd #
63
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
Automated classification of disease response in radiology reports using natural language processing.
First Author: Hai Xiang Ong
Poster
2023 ASCO Annual Meeting
Development of a novel blood-based RNA gene expression platform for early-stage lung cancer diagnosis.
First Author: Martin J Keiser III
Poster
2023 ASCO Annual Meeting
Clinical validation of an activity-based enzyme assay for early stage lung cancer.
First Author: Paul W. Dempsey
Poster
2023 ASCO Annual Meeting
Assessment of electronic health record (EHR) –based machine learning (ML) in predicting risk of brain metastasis among patients with early-stage non–small-cell lung cancer (eNSCLC).
First Author: Hossein Honarvar